Gene · 6646
Papers1,513
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,513
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Methylation analysis by targeted bisulfite sequencing in large for gestational age (LGA) newborns: the LARGAN cohort. | Clin Epigenetics | 2023 | 38093359 | PubTator, text mining | PubMed |
| Integrated omics landscape of hepatocellular carcinoma suggests proteomic subtypes for precision therapy. | Cell Rep Med | 2023 | 38091986 | PubTator, text mining | PubMed |
| Dysregulated cholesterol regulatory genes in hepatocellular carcinoma. | Eur J Med Res | 2023 | 38071335 | PubTator, text mining | PubMed |
| Albumin/Mitotane Interaction Affects Drug Activity in Adrenocortical Carcinoma Cells: Smoke and Mirrors on Mitotane Effect with Possible Implications for Patients' Management. | Int J Mol Sci | 2023 | 38069023 | PubTator, text mining | PubMed |
| Multiplex immunohistochemistry defines two cholesterol metabolism patterns predicting immunotherapeutic outcomes in gastric cancer. | J Transl Med | 2023 | 38062450 | PubTator, text mining | PubMed |
| Efficacy and underlying mechanisms of berberine against lipid metabolic diseases: a review. | Front Pharmacol | 2023 | 38034996 | PubTator, text mining | PubMed |
| Reversible translocation of acyl-CoA:cholesterol acyltransferase (ACAT) between the endoplasmic reticulum and vesicular structures. | Front Mol Biosci | 2023 | 38028547 | PubTator, text mining | PubMed |
| Cholesterol esterification and p53-mediated tumor suppression. | Explor Target Antitumor Ther | 2023 | 38023993 | PubTator, text mining | PubMed |
| Identification of non-conventional small molecule degraders and stabilizers of squalene synthase. | Chem Sci | 2023 | 38023519 | PubTator, text mining | PubMed |
| Cholesterol in colorectal cancer: an essential but tumorigenic precursor? | Front Oncol | 2023 | 38023258 | PubTator, text mining | PubMed |
| Kinetic modelling of sterol transport between plasma membrane and endo-lysosomes based on quantitative fluorescence and X-ray imaging data. | Front Cell Dev Biol | 2023 | 38020900 | PubTator, text mining | PubMed |
| Potential Targets and Mechanisms of Bitter Almond-Licorice for COVID-19 Treatment Based on Network Pharmacology and Molecular Docking. | Curr Pharm Des | 2023 | 38018195 | PubTator, text mining | PubMed |
| Proteomic characterization of epithelial ovarian cancer delineates molecular signatures and therapeutic targets in distinct histological subtypes. | Nat Commun | 2023 | 38016970 | PubTator, text mining | PubMed |
| Indole Diterpenes from Mangrove Sediment-Derived Fungus Penicillium sp. UJNMF0740 Protect PC12 Cells against 6-OHDA-Induced Neurotoxicity via Regulating the PI3K/Akt Pathway. | Mar Drugs | 2023 | 37999417 | PubTator, text mining | PubMed |
| 27-Hydroxylation of oncosterone by CYP27A1 switches its activity from pro-tumor to anti-tumor. | J Lipid Res | 2023 | 37981011 | PubTator, text mining | PubMed |
| Ferroptosis sensitization in glioma: exploring the regulatory mechanism of SOAT1 and its therapeutic implications. | Cell Death Dis | 2023 | 37980334 | PubTator, text mining | PubMed |
| Fatty acids abrogate the growth-suppressive effects induced by inhibition of cholesterol flux in pancreatic cancer cells. | Cancer Cell Int | 2023 | 37978383 | PubTator, text mining | PubMed |
| RNF149 Promotes HCC Progression through Its E3 Ubiquitin Ligase Activity. | Cancers (Basel) | 2023 | 37958377 | PubTator, text mining | PubMed |
| Cholesterol Metabolism in Pancreatic Cancer. | Cancers (Basel) | 2023 | 37958351 | PubTator, text mining | PubMed |
| PPIH gene regulation system and its prognostic significance in hepatocellular carcinoma: a comprehensive analysis. | Aging (Albany NY) | 2023 | 37874737 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6646/papers?page=8